CAS 2126040-21-7

2-(3-Chloro-4-fluorophenyl)-N-(1-cyclohexyl-3-methyl-1H-pyrazol-5-yl)acetamide

CAS: 2126040-21-7

Formula: C₁₈H₂₁ClFN₃O

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 349.8302

Ref: IN-DA01KK1V

VU0810464

CAS: 2126040-21-7

VU0810464

Purezza: ≥98%

Peso molecolare: 349.83g/mol

Ref: 54-BUP08706

VU0810464

CAS: 2126040-21-7

VU0810464 is a non-ureaG protein-gated inwardly-rectifying potassium channels (GIRK, Kir3) activator.

Formula: C₁₈H₂₁ClFN₃O

Purezza: 99.62%

Colore e forma: Solid

Peso molecolare: 349.83

Ref: TM-T7899

3-​Chloro-​N-​(1-​cyclohexyl-​3-​methyl-​1H-​pyrazol-​5-​yl)​-​4-​fluoro-benzeneacetamide

CAS: 2126040-21-7

3-Chloro-N-(1-cyclohexyl-3-methyl-1H-pyrazol-5-yl)-4-fluoro­benzeneacetamide is a potent and selective inhibitor of the insulin receptor. It binds to the extracellular domain of the insulin receptor, preventing it from binding to its ligands. The inhibition of the insulin receptor leads to a reduction in glucose uptake and an increase in glycogen synthesis. This agent also inhibits ion channels such as voltage gated sodium channels. 3-Chloro-N-(1-cyclohexyl-3-methyl-1H­ pyrazol­5­yl)-4­fluoro­benzeneacetamide has been shown to act as an agonist at alpha2A adrenergic receptors, leading to increased blood pressure.

Formula: C₁₈H₂₁ClFN₃O

Purezza: Min. 95%

Peso molecolare: 349.8 g/mol

Ref: 3D-BKD04021